Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects

European Journal of Clinical Pharmacology

Volumn 56, Issue 9-10, 2000, Pages 665-670

  Hassan Alin, M ^a   Andersson, T ^a   Bredberg, E ^a   Rohss, K ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Esomeprazole; Pharmacokinetics; Single dose; Steady state

Indexed keywords

DRUG METABOLITE; ESOMEPRAZOLE;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG METABOLISM; FEMALE; FIRST PASS EFFECT; HUMAN; HUMAN EXPERIMENT; ISOMER; LIQUID CHROMATOGRAPHY; MALE; NORMAL HUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL ANALYSIS;

ADMINISTRATION, ORAL; ADULT; ALGORITHMS; AREA UNDER CURVE; BIOTRANSFORMATION; ENZYME INHIBITORS; FEMALE; HALF-LIFE; HUMANS; INJECTIONS, INTRAVENOUS; MALE; OMEPRAZOLE; PROTON PUMPS; SPECTROPHOTOMETRY, ULTRAVIOLET; STEREOISOMERISM;

EID: 0034466498     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280000206     Document Type: Article

References (17)

1. Pharmacokinetics, metabolism and interactions of acid pump inhibitors
2. Stereoselective metabolism of omeprazole by human cytochrome P450 enzymes
3. Pharmacokinetics “PK” and effect on pentagastrin stimulated peak acid output “PAO” of omeprazole and its 2 optical isomers, S-omeprazole/esomeprazole “E” and R-omeprazole “R-O”
4. Esomeprazole provides improved acid control vs omeprazole in patients with symptoms of gastro-oesophageal reflux disease
5. Determination of omeprazole and metabolites in plasma and urine by liquid chromatography
6. Gender effects in pharmacokinetics and pharmacodynamics
7. Effect of age and gender on the activity of human hepatic CYP3A
8. Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism
9. Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism
10. The pharmacokinetics of single and repeated once-daily doses of 10, 20 and 40 mg omeprazole as enteric-coated granules
11. Effect of intravenous and oral omeprazole on 24-hour intragastric acidity in duodenal ulcer patients
12. Bioavailability of omeprazole as enteric coated “EC” granules in conjunction with food on the first and seventh days of treatment
13. Effect of omeprazole - A gastric proton pump inhibitor - On pentagastrin stimulated acid secretion in man
14. max of esomeprazole on acid secretion and intragastric pH
15. Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolisers of omeprazole
16. Isolation and characterization of human liver cytochrome P450 2C19: Correlation between 2C19 and S-mephenytoin 4-hydroxylation